TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT06570772

Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“The study has been terminated based on Sponsor decision. This decision is not related to any safety concerns associated with the investigational products. It is related to the fact that study will be not required for product dossier submission.”

The sponsor’s own words in the registry.

Life of this trial

202420252026Registered2024-08-22Started2024-09-23Stopped2025-11-25

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
Alvotech Swiss AG
Sponsor type
Industry
Conditions
Ulcerative Colitis
Interventions
AVT16; Vedolizumab
Participants
301
Sites
100
Countries
Argentina, Bulgaria, Croatia, Georgia, Latvia, Poland, Romania, Serbia, Slovakia, Sri Lanka, Ukraine

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.